Roger Mills Net Worth & Insider Trades

Roger Mills - EVP, Acadia Pharmaceuticals Inc

As of March 24, 2015

What is Roger Mills's Net Worth?

The current estimated net worth of Acadia Pharmaceuticals Inc's EVP, Roger Mills, is estimated to be about $2.39M . Roger Mills owns about 18,550 units of Acadia Pharmaceuticals Inc common stock. In the last 9 years at Acadia Pharmaceuticals Inc, Roger Mills has sold an estimated value of $2.1M worth.

What is Roger Mills's Past Insider Trading?

Roger Mills's largest sale order was 35,965 units , worth over $899.31K on September 20, 2013. In total, Roger Mills has made about 13 transactions over 9 years of their time at Acadia Pharmaceuticals Inc. Roger Mills usually trades in March, with the busiest year in 2013. The most recent transaction was a sale order of 25,000 units , worth over $752.26K on November 26, 2014.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Roger Mills

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Roger Mills's' Mailing Address?

  • Mailing address is 3911 Sorrento Valley Boulevard San Diego CA 92121 CA

What are Acadia Pharmaceuticals Inc's Past Insider Trades?

Acadia Pharmaceuticals Inc's most recent insider trade came on September 19, 2023 by James Kihara who sold 2,000 units worth $51.76K . In the last 19 years, insiders at Acadia Pharmaceuticals Inc have sold an estimated value of $131.38M and bought an estimated value of $629.01M worth of shares. Insider trading is most common in June, with the busiest year in 2013. The most active traders at the company are Uli Hacksell, CEO,  Glenn Baity, EVP AND GC,  and Stephen Davis, CEO .

ACADIA PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...